Search

Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. and have partnered with Takeda Pharmaceutical Company, Ltd.

… Tuesday, October 1, 2013 Pioneering Collaboration with Research-Based Global Pharmaceutical Company to Conduct Early-Stage Drug Discovery New Powerhouse for Therapeutic Research Founded with $20 Million in Generous Support from Lewis Sanders and Howard Milstein Memorial Sloan Kettering Cancer Center,

A new study by researchers at Memorial Sloan Kettering Cancer Center finds that even the sickest cancer patients are willing and able to "self-report" symptoms using the Internet, thus supplying key data in real time to their healthcare providers.

… Thursday, November 29, 2007 Traditionally, clinicians have relied on information provided by cancer patients during their office visits as the primary means of assessing patients’ symptoms and side effects. However, potentially serious consequences could arise if important symptoms go unreported during

… Tuesday, May 5, 2026 March 2008 - Three Gerstner Sloan Kettering students — Eric Alonzo, Kim Png, and Ly Vu — have been awarded grants for their potential not only in pursuing meaningful scientific research but in playing a role in such diverse goals as fostering relationships between nations, ensuring

Computational biology researchers today announced a new Internet tool for the exploration of the scientific literature in medicine and biology. The freely accessible iHOP service provides fast, accurate, comprehensive, and up-to-date summary information on more than 80,000 biological molecules by automatically extracting key sentences from millions of PubMed documents when a search is requested.

… Thursday, December 7, 2006 Computational biology researchers today announced a new Internet tool for the exploration of the scientific literature in medicine and biology. The freely accessible iHOP service provides fast, accurate, comprehensive, and up-to-date summary information on more than 80,000

Today MSK issued a statement regarding its financial results for its fiscal year 2025.

… Tuesday, March 31, 2026 MSK reported a deficiency of operating revenues over expenses totaling ($47.9) million and an operating cash flow margin of 3.7% for 2025. These results reflect planned one-time investments related to the go-live of the Epic electronic health record (EHR) system alongside higher

Cell biologists are finding surprising overlaps between a particular form of programmed cell death and the process of wound detection.

… Wednesday, January 1, 2020 Cell biologist Philipp Niethammer left the camera running while he went to get a cup of coffee. Aimed at tiny zebrafish bathing in a translucent dish, the camera was recording the movements of immune cells as they migrated through the fish’s tail fins toward the tip of a pipette

A new treatment option for people with acute myeloid leukemia is available, and it works in an unconventional way.

… Wednesday, August 2, 2017 Summary Acute myeloid leukemia is a rare but hard-to-treat blood cancer that primarily affects older adults. The FDA has approved a new medicine for the disease that works in a manner different from standard chemotherapies. The US Food and Drug Administration has approved the

The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center sets a new benchmark for sustainability and resiliency in a healthcare facility.

… Tuesday, December 10, 2019 The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center sets a new benchmark for sustainability and resiliency in a healthcare facility. “Safety, coupled with a healthy indoor environment, is the most important assurance we can offer patients, which

Research from Sloan Kettering Institute immunologists suggests that the body may mount an immune response to respiratory viruses that lasts longer than previously thought. The discovery could impact the timing of COVID-19 vaccinations.

… Thursday, December 2, 2021 When Sloan Kettering Institute (SKI) postdoctoral fellow William “Teddy” Yewdell embarked on a new research project in 2015, he didn’t know it ultimately could help in fighting a global pandemic. Dr. Yewdell studies how the immune system responds to viruses, including how to

Lisa DeAngelis, MD, Chief Physician Executive and Scott M. and Lisa G. Stuart Chair of Memorial Sloan Kettering Cancer Center (MSK), has been named to amNY Metro and PoliticsNY’s Power Players in Healthcare list.

… Wednesday, November 29, 2023 Lisa DeAngelis, MD, Chief Physician Executive and Scott M. and Lisa G. Stuart Chair of Memorial Sloan Kettering Cancer Center (MSK), has been named to  amNY Metro  and  PoliticsNY ’s Power Players in Healthcare list. The list acknowledges and celebrates healthcare leaders